KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Preferred Dividend Payments: 2015-2018

Historic Preferred Dividend Payments for Neogenomics (NEO) over the last 2 years, with Jun 2018 value amounting to $2.8 million.

  • Neogenomics' Preferred Dividend Payments rose 198.28% to $2.8 million in Q2 2018 from the same period last year, while for Jun 2018 it was $7.4 million, marking a year-over-year decrease of 51.98%. This contributed to the annual value of $5.6 million for FY2018, which is 46.65% down from last year.
  • Per Neogenomics' latest filing, its Preferred Dividend Payments stood at $2.8 million for Q2 2018, which was up 176.27% from $1.0 million recorded in Q1 2018.
  • Over the past 5 years, Neogenomics' Preferred Dividend Payments peaked at $8.0 million during Q4 2016, and registered a low of $122,000 during Q4 2015.
  • Its 3-year average for Preferred Dividend Payments is $3.4 million, with a median of $2.7 million in 2017.
  • Per our database at Business Quant, Neogenomics' Preferred Dividend Payments soared by 6,435.25% in 2016 and then tumbled by 83.94% in 2017.
  • Over the past 4 years, Neogenomics' Preferred Dividend Payments (Quarterly) stood at $122,000 in 2015, then surged by 6,435.25% to $8.0 million in 2016, then tumbled by 66.25% to $2.7 million in 2017, then spiked by 198.28% to $2.8 million in 2018.
  • Its Preferred Dividend Payments was $2.8 million in Q2 2018, compared to $1.0 million in Q1 2018 and $2.7 million in Q4 2017.